Publicaciones en las que colabora con Coral Mouriño Rodriguez (17)

2024

  1. Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist's judgement?

    Rheumatology (Oxford, England), Vol. 63, Núm. 1, pp. 72-78

  2. Novel endothelial progenitor cells populations as biomarkers of damage and remission in systemic lupus erythematosus

    Arthritis Research and Therapy, Vol. 26, Núm. 1

  3. Rate of severe and fatal infections in a cohort of patients with interstitial lung disease associated with rheumatoid arthritis: a multicenter prospective study

    Frontiers in Immunology, Vol. 15

  4. Semaphorin3B promotes an anti-inflammatory and pro-resolving phenotype in macrophages from rheumatoid arthritis patients in a MerTK-dependent manner

    Frontiers in Immunology, Vol. 14

2023

  1. Analysis of comorbidity in rheumatoid arthritis–associated interstitial lung disease: a nested case-cohort study

    Biomedicine and Pharmacotherapy, Vol. 157

  2. Does expert opinion match the definition of lupus low disease activity state? Prospective analysis of 500 patients from a Spanish multicentre cohort

    Rheumatology (Oxford, England), Vol. 62, Núm. 3, pp. 1162-1169

  3. Type I Interferons induce endothelial destabilization in Systemic Lupus Erythematosus in a Tie2-dependent manner

    Frontiers in Immunology, Vol. 14

2022

  1. Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure

    Seminars in Arthritis and Rheumatism, Vol. 52

  2. Safety and Effectiveness of Abatacept in a Prospective Cohort of Patients with Rheumatoid Arthritis–Associated Interstitial Lung Disease

    Biomedicines, Vol. 10, Núm. 7

2021

  1. Contributions of the lupus register of the Spanish Society of Rheumatology (RELESSER) to the knowledge of systemic lupus erythematosus in Spain

    Reumatologia Clinica, Vol. 17, Núm. 5, pp. 245-249

2020

  1. Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 4, pp. 657-662

2019

  1. Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER)

    Seminars in Arthritis and Rheumatism, Vol. 48, Núm. 6, pp. 1025-1029

2017

  1. Anti-CD26 autoantibodies are involved in rheumatoid arthritis and show potential clinical interest

    Clinical Biochemistry, Vol. 50, Núm. 16-17, pp. 903-910

  2. Fibromyalgia prevalence and associated factors in primary Sjögren's syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER)

    Clinical and Experimental Rheumatology, Vol. 35, pp. 28-34

2015

  1. CD26 Expression on T helper populations and sCD26 serum levels in patients with rheumatoid arthritis

    PLoS ONE, Vol. 10, Núm. 7

  2. Classification of systemic lupus erythematosus: Systemic Lupus International Collaborating Clinics versus American College of Rheumatology criteria. A comparative study of 2,055 patients from a real-life, international systemic lupus erythematosus cohort

    Arthritis Care and Research, Vol. 67, Núm. 8, pp. 1180-1185

  3. Erratum: CD26 expression on T helper populations and sCD26 serum levels in patients with rheumatoid arthritis (PLoS ONE (2015) 10:7 (e0131992) (DOI:10.1371/journal.pone.0131992))

    PLoS ONE